Single-agent belantamab mafodotin for relapsed/refractory...

Blood Cancer Journal 2020 / 10 Vol. 10; Iss. 10

Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study

Richardson, Paul G., Lee, Hans C., Abdallah, Al-Ola, Cohen, Adam D., Kapoor, Prashant, Voorhees, Peter M., Hoos, Axel, Wang, Karrie, Baron, January, Piontek, Trisha, Byrne, Julie, Richmond, Scott, Jew
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Journal:
Blood Cancer Journal
DOI:
10.1038/s41408-020-00369-0
Date:
October, 2020
File:
PDF, 478 KB
2020
Conversion to is in progress
Conversion to is failed